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1. Introduction 
As it is known the endocrine system together with the nervous system enables other 
systems in the body to work in coordination with each other and protect homeostasis using 
hormones. Hormones secreted by the endocrine system are carried to target organs and 
cause affect through receptors. 
2. Anatomy 
The thyroid gland is among the most significant organs of the endocrine system and has a 
weight of 15-20g. It is soft and its colour is red. This organ is located between the C5-T1 
vertebrae of columna vertebralis, in front of the trachea and below the larynx. It is 
comprised of two lobes (lobus dexter and lobus sinister) and the isthmus that binds them 
together (Figure 1a). Capsule glandular which is internal and external folium of thyroid 
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gland is wrapped up by a fibrosis capsule named thyroid. The thyroid gland is nourished by 
a thyroidea superior that is the branch of a. carotis external and a. thyroid inferior that is the 
branch of a. subclavia (Figure 1b) (Di Lauro & De Felice, 2001; Dillmann, 2004; Ganong, 
1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & 
Singer, 1997; Mc Gregor, 1996; Snell, 1995; Utiger, 1997). 
In addition, there are 4 parathyroid glands in total, two of which are on the right and the 
other two are on the left in between capsule foliums and behind the thyroid gland lobes 
(Figure 1b) (Di Lauro & De Felice, 2001; Dillmann, 2004; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Snell, 1995; Utiger, 1997).  
 
Fig. 1b. The thyroid gland anatomy with vessels  
3. Embryology and histology 
The thyroid gland develops from the endoderm by a merging of the 4th pouch parts of the 
primitive pharynx and tongue base median line in the 3rd gestational week. By fetus 
organifying iodine in the 10th gestational week and commencing the thyroid hormone 
synthesis, T4 (L-thyroxin) and TSH (thyroid stimulating hormone) can be measured in fetal 
blood. Due to the fact that hormone and thyroglobulin syntheses in fetal thyroid increase in 
the 2nd trimester, an increase is also observed in T4 and TSH amounts. In addition, the 
development of fetal hypothalamus contributes to the synthesizing of TRH (thyroid releasing 
hormone) and thus TSH increase. While TRH can be passed from mother to fetus through the 
placenta, TSH cannot. T3 (3,5,3’-triiodo-L-thyronine) begins increasing at the end of the 2nd 
trimester and is detected in fetal blood in small amounts. Its synthesis increases after birth. 
The development of the thyroid gland is controlled by thyroid transcription factor 1 (TTF-1 
or its other name NKX2A), thyroid transcription factor 2 (TTF-2 or FKHL15) and paired 
homeobox-8 (PAX-8). (Di Lauro & De Felice, 2001; Dillmann, 2004; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
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With these transcription factors working together, follicular cell growth and the 
development of such thyroid-specific proteins as TSH receptor and thyroglobulin is 
commenced. If any mutation occurs in these transcription factors, babies are born with 
hypothyroidism due to thyroid agenesis or insufficient secretion of thyroid hormones. (Di 
Lauro & De Felice, 2001; Dillmann, 2004; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Scanlon, 2001; 
Snell, 1995; Utiger, 1997).  
The fundamental functional unit of the thyroid gland is the follicle cells and their diameter 
is in the range of 100-300 µm. Follicle cells in the thyroid gland create a lumen, and there 
exists a protein named thyroglobulin that they synthesize in the colloid in this lumen 
(Figure 2a-b). The apical part of these follicle cells make contact with colloidal lumen and its 
basal part with blood circulation through rich capillaries. Thus, thyroid hormones easily 
pass into circulation and can reach target tissues. Parafollicular-c cells secreting a hormone 
called calcitonin that affects the calcium metabolism also exist in this gland (Di Lauro & De  
 
Fig. 2a. Thyroid follicule cell in the inactive state 
 
Fig. 2b. Thyroid follicule cell in the active state  
Colloid Flat cell 
Parafollicular cell 
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Felice, 2001; Dillmann, 2004; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; 
Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Scanlon, 2001; Snell, 1995; 
Utiger, 1997). 
4. Physiology 
The thyroid gland synthesizes and secretes T3 and T4 hormones and these hormones play an 
important role in the functioning of the body.  
4.1 Iodine metabolism  
Chemicals in the organism are divided into two as organic and inorganic according to their 
carbon contents. Organic compounds always contain carbon and have covalent bonds. 
Carbohydrates, fats, proteins, nucleic acids, enzymes, and adenosine triphosphate (ATP) are 
the organic compounds. Inorganic compounds have simple structures and do not contain 
carbons except for carbon dioxide (CO2) and bicarbonate ion (HCO3-1). They contain ionic 
and covalent bonds in their structures. Water, acid, base, salt, and minerals are the inorganic 
forms. Iodine that is a trace element important for life is among these minerals and is the 
fundamental substance for thyroid hormones (T3 and T4) synthesis. Iodine exists in 3 forms 
in the circulation. The first one is inorganic iodine (I-) and is about 2-10 µg/L. Secondly, it 
exists sparingly in organic compounds before going into the thyroid hormone structure. 
And the third is the most important one and it is present as bound to protein in thyroid 
hormones (35-80 µg/L). About 59% and 65%, respectively, of the molecular weights of T3 
and T4 hormones are comprised of iodine. This accounts for 30% of iodine in the body. The 
remaining iodine (approximately 70%) exists in a way disseminated to other tissues such as 
mammary glands, eyes, gastric mucosa, cervix, and salivary glands, and it bears great 
importance for the functioning of these tissues (Di Lauro & De Felice, 2001; Dillmann, 2004; 
Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti 
& Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997).  
The daily intake is recommended by the United States Institute of Medicine as in the range 
of 110-130 µg for babies up to 12 months, 150 µg for adults, 220 µg for pregnant women, and 
290 µg for women in lactation (Di Lauro & De Felice, 2001; Dillmann, 2004; Ganong, 1997; 
Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 
1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997).  
Iodine is taken into the body oral. Among the foods that contain iodine are seafood, iodine-
rich vegetables grown in soil, and iodized salt. For this reason, iodine intake geographically 
differs in the world. Places that are seen predominantly to have iodine deficiency are icy 
mountainous areas and daily iodine intake in these places is less than 25 µg. Hence, diseases 
due to iodine deficiency are more common in these geographies. Cretinism in which mental 
retardation is significant was first identified in the Western Alps (Di Lauro & De Felice, 2001; 
Dillmann, 2004; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 
2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995 Utiger, 1997). 
4.2 Thyroid hormone synthesis 
Iodine absorbed from the gastrointestinal system immediately diffuses in extracellular fluid. 
T3 and T4 hormones are fundamentally formed by the addition of iodine to tyrosine 
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aminoacids. While the most synthesized hormone in thyroid gland is T4, the most efficient 
hormone is T3. (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997). Basely, thyroid hormone synthesis occurs in 4 stages: 
1st stage is the obtaining of iodine by active transport to thyroid follicle cells by utilizing 
Na+/I- symporter pump. Starting and acceleration of this transport is under the control of 
TSH. Organification increases as the iodine concentration of the cell rises, however, this 
pump slows down and stops after a point. For this reason, it is believed that a concentration-
dependent autocontrol mechanism exists at this level. This stage of the synthesis that is the 
iodine transport can be inhibited by single-value anions such as perchlorate, pertechnetate, 
and thiocyanate. Pertechnetate (99mm) is also used in thyroid gland imaging due to its 
characteristic of being radioactive (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997).  
2nd stage is oxidation of iodine by NADPH dependent thyroperoxidase enzyme in the 
presence of H2O2 which, at this stage, occurs in follicular lumen. The drugs propylthiouracil 
and methimazole inhibit this step (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997). 
3rd stage is the binding of oxidized iodine with thyroglobulin tyrosine residues. This is called 
iodization of tyrosine or organification. Thus, monoiodotyrosine (MIT) or diiodotyrosine 
(DIT) is synthesized. These are the inactive thyroid hormone forms (Figure 3) (Dillmann, 
2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et 
al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997). 
 
Fig. 3. Chemical structures of tyrosine, monoiodothyronine, and diiodothyronine  
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4th stage is the coupling and T3 and T4 are synthesized from MIT and DIT (Figure 4). 
 3MIT+DIT T    (1) 
 4DIT+DIT T  (2) 
 
Fig. 4. Chemical structures of triiodothyronine, thyroxin, and revers T3 
In addition to synthesizing this way, the T3 hormone is also created by the metabolization 
of T4.  
Almost the entire colloid found in each thyroid follicle lumen is thyroglobulin. 
Thyroglobulin that contains 70% of thyroid protein content is a glycoprotein with a 
molecular weight of 660 kDa. Each thryoglobulin molecule has 70 tyrosine aminoacids 
and contains 6 MIT, 4 DIT, 2 T4, and 0.2 T3 residues. Thyroglobulin synthesis is TSH-
dependent and occurs in the granulose endoplasmic reticulum of the follicle cells of the 
thyroid gland. The synthesized thyroglobulin is transported to the apical section of the 
cell and passes to the follicular lumen through exocytose, and then joins thyroid hormone 
synthesis (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997).  
4.3 Thyroid hormone secretion  
Thyroid hormones are stocked in the colloid of follicle cells lumen in a manner bound to 
thyroglobulin. With TSH secretion, apical microvillus count increases and colloid droplet is 
caught by microtubules and taken back to the apex of the follicular cell through pinocytosis. 
Lysosomes approach these colloidal pinocytic vesicles containing thyroglobulin and thyroid 
hormones. These vesicles bind with lysosomes and form fagolysosomes. Lysosomal 
proteases are activated while these fagolysosomes move towards the basal cell, and thus, 
thyroglobulin is hydrolyzed. Tyrosine formed as a result of this reaction is excreted by T3 
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and T4 facilitated diffusion (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 
1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 
1996; Reed & Pangaro, 1995; Utiger, 1997). 
Not all hormones separated from thyroglobulin can pass to the blood. Such iodotyronines as 
MIT and DIT cannot leave the cell and are reused as deiodonized. In addition, T3 is formed 
from a certain amount of T4 again by deiodonization. These reactions occur in the thyroid 
follicular cell and the enzyme catalyzing these reactions, in other words, deiodinizations is 
dehalogenase. Through this deiodinization, about 50% of iodine in the thyroglobulin 
structure is taken back and can be reused. Iodine deficiency in individuals lacking this 
enzyme, and correspondingly, hypothyroid goiter is observed. Such patients are given 
iodine replacement treatment (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 
1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 
1996; Reed & Pangaro, 1995; Utiger, 1997).  
4.4 Thyroid hormone transport 
When thyroid hormones pass into circulation, all become inactive by reversibly binding to 
carrier proteins that are synthesized in the liver. While those being bound to proteins 
prevent a vast amount of hormones to be excreted in the urine, it also acts as a depository. 
Thus, free, in other words, active hormone exists in blood only as much as is needed. The 
main carrier proteins are thyroxin-binding globulin (TBG), thyroxin-binding prealbumin 
(transthyretin, TTR) and serum albumin (Table 1) (Benvenga, 2005; Dillmann, 2004; Dunn, 
2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo 
Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997).  
TBG is the most bound protein by thyroid hormones. Its molecular weight is 54 kDa and is 
has the least concentration among others in circulations. The hormone that binds to this 
protein the most is T4 and is about 75% of T4 hormone. This is responsible for the diffusion 
of T4 hormone in extracellular fluid in large amounts. However, T3 is bound in fewer 
amounts. While TBG rise increases total T3 and total T4, it does not affect free T3 and T4 
(Benvenga, 2005; Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson 
& Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997). 
And TTR has a weight of 55kDa and has a lower rate of binding although its plasma 
concentration is less than TBG, and this value is more or less around 1/100 (Benvenga, 
2005; Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997). 
Serum albumin is a protein with a molecule weight of 65kDa and has a lower rate of binding 
even though its plasma concentration is the highest (Benvenga, 2005; Dillmann, 2004; Dunn, 
2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo 
Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997). 
Due to the fact that T3 binds to fewer proteins, it is more active in intracellular region. While 
they become free when needed because of the fact that the affinity of carrier proteins is more 
to T4, the half-life of T4 is about six days, whereas the half-life of T3 is less than one day. T3 is 
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more active since T4 binds to cytoplasmic proteins when they enter the cell are going to 
affect (Benvenga, 2005; Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 






Levels of binding 
thyroxin-binding 
(TBG) 
54 Lowest Highest 
thyroxin-binding 
prealbumin ( TTR) 
55 Higher Lower 
Albumin 65 Highest Lowest 
Table 1. Comparison of the binding of thyroid hormones to carrier proteins 
4.5 Thyroid hormone metabolism 
A 100 µg thyroid hormone is secreted from the thyroid gland and most of these hormones 
are T4. About 40% of T4 turn into T3 which is 3 times stronger in periphery, especially in the 
liver and kidney with deiodinase enzymes (Dillmann, 2004; Dunn, 2001; Ganong, 1997; 
Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 
1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997). 
Metabolically, in order for active T3 to form, deiodination needs to occur in region 5’ of 
tyrosine. Instead, if it occurs in the 5th atom of inner circle, metabolically inactive reverse 
triiodothyronine (rT3) is formed. Three types of enzymes that are Selenoenzyme 5’- 
deiodinase type I (5’-DI), the type II5’ iodothyronine deiodinase (5’-DII) and the 5, or inner 
circle deiodinase type III (5-DIII) catalyze these deiodinations (Dillmann, 2004; Dunn, 2001; 
Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti 
& Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997).  
5’-DI enzyme is especially found in the liver, kidneys, and thyroid, and 5’-DII enzyme exists 
in the brain, hypophysis, placenta, and keratinocytes. 5’-DIII is found in the brain, placenta, 
and epidermis. Both 5’-DI and 5’DII enzymes allow T4 to transform into active T3; but with 
one difference, that is, while 5’- DI enzyme provides the formed T3 to plasma, T3 formed by 
5’-DII enzyme stays in the tissue and regulates local concentration. This enzyme is regulated 
by increases and decreases in thyroid hormones. For instance, hyperthyroidism inhibits 
enzyme and blocks the transformation from T4 to T3 in such tissues as the brain and 
hypophsis. Transformation from T4 to T3 is affected by such changes in the organism as 
hunger, systemic disease, acute stress, iodine contrating agents, and drugs such as 
propiltiourasil, propranolol, amiodaron, and glicocortikoid, but is not affected by 
metrmazol. 5’-DIII enzyme transforms T4 into metabolically inactive reverse T3 (rT3) (Figure 
5) (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Utiger, 1997). As mentioned earlier, 40% of T4 is used for the formation of T3. This 
constitutes 90% of T3. Only 10% of T3 is formed directly. Also, 40% of T4 is used for the 
formation of reverse T3 (rT3). The remaining 20% is excreted with urine or feces. 
www.intechopen.com
 Introduction to Thyroid: Anatomy and Functions 11 
 
Fig. 5. Effects of deiodinase enzymes 
4.6 Controlling the thyroid hormone synthesis and secretion 
Synthesis and secretions need to be kept at a certain level in order for the liveliness of 
thyroid hormones to be maintained. In this respect, the most important mechanism in 
controlling the synthesis and secretion of thyroid hormones is the hypothalamus-
hypophysis-thyroid axis. Another one is the autocontrol mechanism that is dependent on 
iodine concentration as noted earlier (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; Utiger, 1997).  
4.6.1 Hypothalamus-hypophysis-thyroid axe 
Hormone synthesis and secretion of the thyroid gland is under the strict control of this axis. 
This event begins with TRH synthesis in the hypothalamus. TRH is carried from the 
hypothalamus to the hypophysis through portal circulation, and TSH hormone is secreted 
here following the interaction with TRH receptors in the hypophysis front lobe. TSH is then 
transferred by blood and stimulates the thyroid gland, and thus, thyroid hormone synthesis 
and secretion begins. However, if thyroid hormone and synthesis is too large an amount, the 
feedback system is activated and TSH and TRH are suppressed (Figure 6) (Dillmann, 2004; 
Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 
2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; 
Scanlon, 2001; Utiger, 1997). 
 
Fig. 6. Controlling of thyroid hormone secretion by the hypothalamus-hypothyroidism-
thyroid axis 
L-thyroxin (T4) 
3,5,3’,5’-tetra iodothyronine  
 
     Deiodinase I or 2                                                      Deiodinase 5’-DIII 
   5’-DI  or 5’-DII 
 
triiodothyronine (T3)   reverse T3 (rT3) 
3, 3,5 Triiodothyronine   3, 3’ 5’     
                                                                                         Triiodothyronine 
 
Hypothalamus    Secretes TRH 
                                   (-) 
        
        
Pituitary lobus  Secretes TSH  
                               (-) 
        
        
Thyroid              Secretes T3 and T4 
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The thyrotrophin-releasing hormone (TRH) is a tripeptide synthesized in periventricular 
nucleus in the hypothalamus. The structure of TRH formed by the repetition of -Glu-H.5-
Pro-Gly- series 6 times in the beginning turns into pyroglutamyl histidylprolinamide at the 
end of synthesis. As noted earlier, TRH is carried to the front hypophysis through 
hypophyseal portal system and provides the secretion of TSH from thyrotrope cells 
(Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Santiseban, 2005; Scanlon, 2001; Utiger, 1997).  
There are receptors specific to TRH on the surfaces of these cells. When TRH makes 
contact with these receptors, Gq protein is activated, and it then activates the 
phosphalipase C enzyme, fractionates membrane phospholipids and forms diacylglycerol 
(DAG) and inositole triphosphate (IP3). These are secondary mesengers and cause the 
secretion of Ca+2 via IP3 from endoplasmic reticulum, and DAG activates protein kinase C. 
The effect of TRH on TSH is provided through these secondary messengers (Dillmann, 
2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen 
et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 
2005; Scanlon, 2001; Utiger, 1997). 
TRH also increases the secretions of growth hormone (GH), follicle stimulating hormone 
(FSH), and prolactin (PRL). While the TRH secretion is increased by noradrenaline, 
somatostatin and serotonin inhibits it. (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton 
& Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; Scanlon, 2001; Utiger, 1997). 
The thyrotropin-stimulating hormone (TSH) is a hormone that has a glycoprotein structure 
comprised of ┙ and ┚ subunits and synthesized in 5% basophilic thyrotrope cells of frontal 
hypophysis. ┙ subunit is almost the same as that found in such hormones as human 
chorionic gonadotropin (HCG), luteinizing hormone (LH), and follicle stimulating hormone 
(FSH). It is believed that the task of this subunit is the stimulation of adenilate cyclase that 
provides the formation of cAMP secondary precursor. ┚ subunit is completely different to 
other hormones and is related with receptor specificity. Therefore, TSH is active when it 
possesses both subunits (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Reed & Pangaro, 1995; Santiseban, 2005; Scanlon, 2001; Utiger, 1997).  
TSH activates Gs protein when it merges with the receptor in the membrane of thyroid 
gland follicle cell, and thus, the adenilat cyclase enzyme is activated as well. When this 
enzyme becomes activated, it increases the secondary messenger cAMP. Along with 
stimulating protein kinase A enzymes, it causes the development of thyroid follicular cell 
and the synthesis of thyroid hormone (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; Scanlon, 2001; Utiger, 1997). 
TSH is metabolized in kidneys and liver. It is released as pulsatile and demonstrates 
circadian rhythm, which means that the secretion begins at night, reaches a maximum at 
midnight, and decreases all day long (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; Scanlon, 2001; Utiger, 1997). 
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The effects of TSH may be divided into three. 
a. Effects occurring within minutes; 
- Binding of iodine, 
- T3 and T4 hormone synthesis 
- Secretion of thyroglobulin into colloid  
- Taking colloid back into the cell with endocytos, 
b. Effects occurring within hours; 
- Trapping iodine into the cell by active transport 
- Increase in blood flow 
c. Chronic effects, 
- Hypertrophy and hyperplasia occurring in cells 
- Gland weight increases. 
Despite these effects, TSH does not affect the transformation from T4 to T3 in the periphery.  
Although TSH secretion is stimulated by TRH and estradiol, it is inhibited by somatostatine, 
dopamine, T3, T4, and glucocorticoids. While ┙ 1 adrenergics demonstrates inhibiting effects, 
┙2 adrenergics are stimulators (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 
1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 
1996; Reed & Pangaro, 1995; Santiseban, 2005; Scanlon, 2001; Utiger, 1997). 
4.6.2 Autoregulation of the thyroid  
Changes in iodine concentrations in follicular cells of thyroid gland affect the iodine 
transport and form an autoregulation (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; Scanlon, 2001; Utiger, 1997). Thyroid 
hormone synthesis is inhibited as the iodine amount increases in follicles, however, 
synthesis increases as the amount decreases. Wolf Chaikoff effect in which excessive iodine 
stops the thyroid hormone synthesis may also be mentioned. This effect is especially 
observed when individuals with hyperthyroidism take antithyroid along with iodine and 
become euthyroid (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Reed & Pangaro, 1995; Santiseban, 2005; Scanlon, 2001; Utiger, 1997).  
In addition, the sensitivity of the thyroid gland also increases through a development of a 
response to TSH, although TSH does not have a stimulating effect in iodine deficiency. 
Along with the increase in sensitivity, follicular cells in the gland reach hypertrophy and 
hyperplasia, and increase the weight of the gland and create goiter. The effects of TSH 
decrease as the response to TSH decreases with the rise in iodine (Dillmann, 2004; Dunn, 
2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; 
Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; 
Scanlon, 2001; Utiger, 1997). In this case, all of the effects, such as binding of iodine, 
thyroid hormone synthesis, secretion of thyroglobulin into colloid, taking colloid back to 
cell by endocytosis, entrapment of iodine, and cell hypertrophy are decreased. However, 
blood flow to the thyroid glands is reduced. Iodine supplement before thyroid surgery is 
for the purpose of reducing the blood flow in the thyroid gland. (Dillmann, 2004; Dunn, 
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2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; 
Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Santiseban, 2005; 
Scanlon, 2001; Utiger, 1997). 
4.7 Occurrence of the thyroid hormone effect 
Thyroid hormone receptors exist within the cell. Most of these receptors are in the nucleus 
and show more affinity to T3. Due to the fact that T4 binds more to carrier proteins and exists 
more in extracellular region, it passes inside the cell, in other words, intracellular amount of 
T4 is lesser. When they pass to the intracellular section, very few of them are free for 
receptors after they are bound to proteins. However, T3 already exists more in intracellular 
section due to it binding to fewer amount of carrier proteins and receptors show more 
affinity to T3 due to being free. As a result, T3 is 3-8 times more potent compared to T4. The 
reason for this difference in effect is that T4 transforms into T3 while T4 exists in high 
amounts; the actual efficient one is T3 (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
Thyroid hormones easily pass through the cell membrane due to being lipid soluble and T3 
immediately binds to thyroid hormone receptor in nucleus. Thyroid hormone receptors are 
of two types as ┙ (TR ┙) and ┚ (TR┚). Although these receptors generally exist in all tissues, 
they differ in effects. While TR ┙ is more efficient in the brain, kidneys, heart, muscles and 
gonads, TR┚ is more efficient in liver and hypophysis. TR ┙ and ┚ are bind to a special DNA 
sequence that has thyroid response elements (TREs). Receptors bind and activate by retinoic 
acid X (RXRs) receptors. They either stimulate transcription or inhibit it due to regulatory 
mechanisms in the target gene. When the transcription starts, various mRNAs are 
synthesized, and various proteins are synthesized by going through translation in 
ribosomes that are present in cell cytoplasm. Also, enzymes in the protein structure are 
synthesized and some of these play an active role in the formation of thyroid hormone 
effects (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997; Usala, 1995).  
4.8 Effects of thyroid hormones  
The effects of thyroid hormones are varying. It can be divided into 4 as cellular level, and 
effects on growth, metabolism, and on systems. 
4.8.1 Effects of thyroid hormones at the cellular level  
The general cellular effect is the aforementioned T3 synthesizing various proteins in which 
enzymes are also included by transcription and then translation in ribosomes in cytoplasm 
after interacting with receptor in nucleus. While, on one hand, protein synthesis increases, 
and on the other, a rise occurs in catabolism, and thus basal metabolism increases. Cell 
metabolism shows an increase of 60-100% when thyroid hormones are oversecreted 
(Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Utiger, 1997; Usala, 1995). 
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Thyroid hormones accelerate mRNA synthesis in mitochondria by acting with intrinsic 
receptors in mitochondria inner and outer membranes and increases protein production. 
Due to these proteins produced here in mitochondria being respiratory chain proteins such 
as NADPH dehydrogenase, cytochrome-c-oxidase, and cytochrome reductase, the 
respiratory chain accelerates as the synthesis of these enzymes increases, and thus, ATP 
synthesis and oxygen consumption also increases. Therefore, it may be noted that ATP 
synthesis is dependent on thyroid hormone stimulation. In addition, the number of 
mitochondria increases due to the increase in mitochondria activity parallel to mitochondria 
protein synthesis (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson 
& Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997; Usala, 1995).  
Protein synthesis causes an increase in enzyme synthesis by increasing with the effect of 
thyroid hormones, and this affects the passage by increasing the production of transport 
enzymes in the cell membrane. Among these enzymes, the Na+- K+- ATPase pump provides 
Na+ to exit and K+ to enter by using ATP, thus, the rate of metabolism also increases 
(Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Utiger, 1997; Usala, 1995). 
Another membrane enzyme Ca+2_ATPase acts more in the circulation system as intracellular 
Ca+2 decreases when this enzyme operates (Dillmann, 2004; Dunn, 2001; Ganong, 1997; 
Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 
1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
4.8.2 Effects on growth 
Among the effects of thyroid is the effect it has on growth. This hormone has both specific 
and general effects on growth. Thyroid hormones are necessary for normal growth and 
muscle development. While children with hypothyroidism are shorter due to early 
epiphysis closure, children with hyperthyroidism are taller compared to their peers. 
Another important effect of the thyroid hormone is its contribution to the pre- and post-
natal development of the brain. When in the mother’s uterus, if the fetus cannot synthesize 
and secrete sufficient thyroid hormone and it is not replaced, growth and development 
retardation occurs in both pre- and post-natal periods (Dillmann, 2004; Dunn, 2001; Ganong, 
1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & 
Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). Normal 
serum levels are Total T4 5-12µg/dl, Total T3 80-200ng/dl, Free T4 0,9-2ng/dl and free 
T3 0,2-0,5ng/dl, respectively. If a thyroid hormone test is conducted on the baby after birth 
and hormone treatment is started immediately, a completely normal child is developed and 
a dramatic difference between early and late detection of the disease is clearly observed. 
4.8.3 Metabolic effects 
Thyroid hormones carry out their metabolic effects by carbohydrates, fat and protein 
metabolisms, vitamins, basal metabolic rate and its effect on body weight. 
When the effects of thyroid hormones on carbohydrate metabolism are observed, it is 
established that it is both anabolic and catabolic. As a result of thyroid hormones increasing 
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the enzyme synthesis due to protein synthesis in cells, enzymes in carbohydrate metabolism 
also increase their activities. Thus, thyroid hormones increase the entrance of glucose into 
the cell, absorption of glucose from the gastrointestinal system, both glycolysis and 
gluconeogenesis, and secondarily, insulin secretion (Dillmann, 2004; Dunn, 2001; Ganong, 
1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & 
Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
The effect of thyroid hormone on fat metabolism are both anabolic and catabolic. Thyroid 
hormones have an especially lipolysis effect on adipose tissue ,and free fatty acid 
concentrations in plasma increase with the said effect, and in addition, fatty acid oxidation 
also increases (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997; Usala, 1995). While, as a result of these effects, an increase is 
expected in the amounts of cholesterol and triglyceride, in contrast, their levels in blood are 
established to be low. This occurs due to two reasons. Firstly, thyroid hormones (especially 
T3) cause an increase in receptor synthesis specific to LDL and cholesterol in liver, bind to 
lipoproteins, and decrease the triglyceride level in blood. Secondly, thyroid hormones 
accelerate the transformation of triglyceride to cholesterol with their effect. Cholesterol 
reaching the liver is used in the production of bile and the produced bile is excreted from 
the intestines with feces. Consequently, there occurs a decrease in adipose tissue, cholesterol 
and triglyceride in blood, and an increase in free fatty acids when thyroid hormone is 
oversecreted. The opposite occurs in individuals with hyperthyroidism. In a study by Bursuk 
et al., it was established by comparing the body composition in control, hypothyroidism, and 
hyperthyroidism groups with the bioelectrical impedance analysis method that body fat 
percentage and the amount decreased in cases with hyperthyroidism while they increased in 
cases with hypothyroidism (Bursuk et al., 2010; Dillmann, 2004; Dunn, 2001; Ganong, 1997; 
Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; 
Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
As previously noted, thyroid hormones show an anabolic effect by increasing the protein 
syntheses and a catabolic effect by increasing the destruction when oversecreted. Thyroid 
hormones also regulate aminoacid transport due to the need for aminoacids in order to 
increase the protein synthesis. They also provide the synthesis for proteins specific to cell 
growth. Thyroid hormones provide a normal growth of the baby by increasing the syntheses 
of insulin-like factors in fetal period (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
Hormones that provide growth and development are also under the control of thyroid 
hormones. As mentioned before, hypothyroidism causes growth-development retardation 
and can be reversed by hormone replacement treatment when diagnosed early. In 
hyperthyroidism in which thyroid hormones are oversecreted, muscle atrophies are 
observed as a result of an increase in protein catabolism (Dillmann, 2004; Dunn, 2001; 
Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti 
& Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
Most of the enzymes need vitamins as co-factors in order to produce an effect. The need for 
the co-factor of thyroid hormones increases parallel to enzyme synthesis. Thiamine, 
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riboflavin, B12, folic acid and ascorbic acid (vitamin C) are predominantly used as co-factors. 
Therefore, deficiencies of these vitamins are common in cases with hyperthyroidism. In 
addition, vitamin D deficiency is also observed in these individuals due to an increase in 
excessive consumption and clearance. Also, thyroid hormones are necessary for carotene 
from food to be transformed into vitamin A. Vitamin A transformation does not occur in 
cases with hypothyroidism due to thyroid hormone deficiency and carotene is deposited 
under the skin giving it a yellow color. (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton 
& Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). Vitamin D deficiency is 
present in these cases due to a problem in A, E, and cholesterol metabolism. Thus, vitamin 
supplement is necessary in both hypothyroidism and hyperthyroidism cases.  
Another effect of thyroid hormones is the acceleration of basal metabolism. As noted 
before, thyroid hormones increase the oxygen consumption and thus ATP synthesis by 
rising the count and activity of mitochondria. Thyroid hormones increase oxygen 
consumption except for the adult brain, testicles, uterus, lymph nodes, spleen, and front 
hypophysis. In addition, the increase of such enzymes as Na+- K+- ATPase, and Ca+- 
ATPase contribute to it. Also, lipid catabolism lends to it. A high level of temperature is 
produced as a result (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
A protein called thermogenin in brown adipose tissue is uncoupled, that is, ATP production 
and e- - transport chain are separated from each other. An excessive temperature occurs as a 
result. All these effects provide acceleration of basal metabolism. The overworking thyroid 
gland increases the basal metabolism by 60-100% (Dillmann, 2004; Dunn, 2001; Ganong, 
1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & 
Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
Due to the increase in basal metabolism, a decrease is observed in body weight. Thyroid 
hormones greatly reduce the fat deposit. Weight loss is observed in cases with 
hyperthyroidism although appetite increases in cases with hyperthyroidism. However, in 
cases with hypothyroidism, basal metabolism deceleration and weight gain occur in cases 
with hypothyroidism (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
4.8.4 Effect of thyroid hormones on systems  
The effect of thyroid hormones on circulation systems is predominantly through 
catecholamine. Thyroid hormones increase the ┚ adrenergic receptor count without 
affecting catecholamine secretion. This causes an increase in heart rate, cardiac output, 
stroke volume, and peripheral vasodilation. Peripheral vasodilation causes the skin to be 
warm and humid. Warm and humid skin, sweating, and restlessness due to increased 
sympathetic activity are observed in cases with hyperthyroidism. However, the opposite 
is seen in hypothyroidism. The ┚ adrenergic receptor count is decreased. In relation to 
this, heart rate, cardiac output, and stroke volume is also decreased and cold, dry skin is 
observed due to peripheral vasoconstriction. In a study by Bursuk et al., it was established 
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by measuring and comparing the stroke volume, cardiac output, heart index, and blood 
flow in control, hypothyroidism, and hyperthyroidism groups with the bioelectrical 
impedance analysis method that these parameters significantly increased in cases with 
hyperthyroidism while they decreased in cases with hypothyroidism (Bursuk et al., 2010; 
Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Utiger, 1997; Usala, 1995). 
In addition, as metabolism products also increase due to an increase in oxygen consumption 
when thyroid hormones are oversecreted, vasodilation occurs in periphery. Thus, blood 
flow increases, and cardiac output can be observed to be 60% more than normal. The 
thyroid hormone also raises the heart rate due to its direct increasing effect on heart 
stimulation (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997; Usala, 1995). 
Thyroid hormones increase the contraction of heart muscles only when they raise it in small 
amounts. When thyroid hormones are oversecreted, a significant decrease occurs in muscle 
strength, and even myocardial infarction is observed in severely thyrotoxic patients 
(Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Utiger, 1997; Usala, 1995). 
Due to large amounts of oxygen thyroid hormones use during their increasing protein 
synthesis, hence the enzyme synthesis, and ATP synthesis as well, carbon dioxide amount is 
also increased. As a result of the carbon dioxide increase affecting the respiratory center of 
the brain, hyperventilation, that is, the rise in inhalation frequency and deepening of 
respiration is observed (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
While appetite and food consumption increases, an increase has also been observed in 
digestive system fluids, secretions, and movements. Frequently, diarrhea occurs when the 
thyroid hormone is excessively secreted. In contrast, constipation is observed in the case of 
hypothyroidism (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson 
& Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997; Usala, 1995). 
When the effects of thyroid hormones on the skeletal system are checked, the first thing that 
needs to be examined is their effect on bones. The activities of osteoblast and osteoclast that 
are the main cells of bone structure increase parallel to thyroid hormones. In normal 
individuals, thyroid hormones possess direct proliferative effect on osteoblasts. In cases 
with hyperthyroidism, a decrease develops in the cortex of the bones due to increase in 
osteoclastic activities. Thus, the risk of post-menopausal osteoporosis development increases 
in these patients. While, in physiological cases, thyroid hormone creates an osteoblastic 
effect, it produces an osteoporotic effect in hyperthyroidism (Dillmann, 2004; Dunn, 2001; 
Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti 
& Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
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The thyroid also affects response to stimulants. When this hormone is excessively 
secreted, muscle fatigue occurs due to protein catabolism increase. The most typical 
symptom of hyperthyroidism is a faint muscle tremor. Such a tremor happening 10-15 
times per second, occurs due to increase in activity of neuronal synapses in medulla 
spinalis regions that control muscle tone, and differs from tremors in Parkinson’s disease. 
This tremor demonstrates the effects of thyroid hormones on central nervous system 
(Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Utiger, 1997; Usala, 1995).  
As mentioned above, muscle fatigue is observed in hyperthyroidism due to the accelerating 
effect of the thyroid hormone on protein catabolism. However, the excessive stimulant effect 
of this hormone on synapses leads to sleeplessness. In hypothyroidism, a sleepy state exists 
(Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 
2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; 
Utiger, 1997; Usala, 1995).. 
Thyroid hormones play an important role in the development of the central nervous system. 
They are also responsible for the myelinization of the nerves. If there is thyroid hormone 
deficiency in fetus, it causes neuronal developmental disorders in the brain, myelinization 
retardation, decrease in vascularization, retardation in deep tendon reflexes, cerebral 
hypoxy due to decrease in cerebral blood flow, mental retardation, and lethargy. In cases 
with hyperthyroidism, the opposite occurs and hyperirritability, anxiety, and sleeplessness 
are observed in these children (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 
1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 
1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
Thyroid hormones produce an effect by merging with their specific receptors in membrane 
and nuclei of hemopoietic stem cells. After T3 and T4 hormones bind with a receptor, 
erythroid stem cells go through mitosis and accelerate erythropoiesis. With the protein 
synthesis they caused to occur in these precursor cells, they provide the synthesis of 
enzymes at the beginning and at the end of hemoglobin synthesis (Dillmann, 2004; Dunn, 
2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo 
Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
In addition, when tissues are left without oxygen with the consumption of oxygen thanks to 
thyroid hormone effect, they stimulate the kidney and increase erythropoietin synthesis and 
secretion. Erythropoietin then stimulates the bone marrow and accelerates erythropoiesis. 
While polycythemia is not observed in patients with hyperthyroidism, anemia is quite 
prevalent among cases with hypothyroidism. Blood levels of cases with hyperthyroidism 
are generally within normal limits (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & 
Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
In a study by Bursuk et al., it has been established by measuring and comparing blood 
parameters and blood viscosity in control, hypothyroidism, and hyperthyroidism groups 
that blood viscosity was increased in cases with hypothyroidism due to blood count 
parameters being higher compared to cases with hyperthyroidism, blood lipids and 
fibrinogen were higher in cases with hypothyroidism, and in addition, blood viscosity 
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was increased in cases with hypothyroidism due to high plasma viscosity (Bursuk et al., 
2010; Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997; Usala, 1995). 
Thyroid hormones regulate the actions of other endocrine hormones in order to accelerate 
basal metabolism. These hormones increase the absorption of glucose in gastrointestinal 
system, glucose reception into cells, and both glycolysis and gluconeogenesis by producing 
an effect on insulin and glucagon. Thyroid hormones enable the increase of insulin through 
secondary mechanism by occasionally rising blood sugar (Dillmann, 2004; Dunn, 2001; 
Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti 
& Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
Due to the fact that both thyroid hormones and growth hormones are necessary for normal 
somatic growth, thyroid hormones increase the synthesis and secretion of growth hormone 
and growth factors (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
Also, another effect is produced on prolactin. During hypothyroidism, TRH secretion 
stimulates prolactin secretion, and while galactorrhea and amenorrhea is observed in 
females, gynecomastia and impotence is found in males. The inhibiting effect of dopamine 
is of utmost importance in regulating the secretion of prolactin secretion (Dillmann, 2004; 
Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 
2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; 
Usala, 1995). 
Due to the fact that thyroid hormones regulate the secretion and use of all steroid hormones 
adrenal gland deficiency with such findings as lack of libido, impotence, amenorrhea, 
menorrhagia, and polymerrhea is observed in cases with hypothyroidism. Another cause for 
findings related to these sex steroids may be excessive prolactin (Dillmann, 2004; Dunn, 
2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo 
Presti & Singer, 1997; Mc Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995).  
Thyroid hormones affect bone metabolism in parallel with parathormone. Estrogen, vitamin 
D3, TGF-┚, PGE2, parathormone (PTH), and all of the thyroid hormones are necessary for 
osteoblastic activity (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; 
Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; 
Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
As noted earlier, thyroid hormones increase ┚ adrenergic receptor count. Adrenaline and 
noradrenaline interact with these receptors and accelerates basal metabolism, stimulates the 
nervous system, and speeds up the circulation system just as in the effect of thyroid 
hormones (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton & Hall, 1997; Jameson & 
Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc Gregor, 1996; Reed & 
Pangaro, 1995; Utiger, 1997; Usala, 1995). 
For a normal sexual development and life, thyroid hormones are necessary. The reason for 
this is that thyroid hormones increase the use and secretion of sex steroids, and in addition, 
affect prolactin secretion. Lack of libido, impotence, gynecomastia, amenorrhea, 
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menorrhagia, and polymenorrhea are observed due to sex steroid deficiency and excessive 
prolactin in cases with hypothyroidism (Dillmann, 2004; Dunn, 2001; Ganong, 1997; Guyton 
& Hall, 1997; Jameson & Weetman, 2010; Larsen et al., 2003; Lo Presti & Singer, 1997; Mc 
Gregor, 1996; Reed & Pangaro, 1995; Utiger, 1997; Usala, 1995). 
5. Conclusion 
Anatomy, histology and physiology of thyroid have been addressed in this chapter. In its 
physiology, its hormone synthesis, metabolism, effect generation mechanism and effects on 
the body has been explained. While mentioning these effects, the relationship between 
thyroid diseases and blood hemorheology has also been referred and relationship between 
disease groups (hyperthyroids and hypothyroids) has been analysed comparatively with 
these parameters.  
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